HWI group

Company

The HWI group is a family-owned, independent service partner in the pharma and biotech sector. It stands for quality, flexibility, competence and reliability.

With 150 colleagues at 3 sites in Ruelzheim, Frankfurt and Appenweier we look back on 30 years of experience.

We offer a service portfolio ranging from formulation development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to pre-clinical development, pharmacovigilance and GxP services.

Together with network partners, HWI also supports clinical and preclinical studies.

Our technology platform for parenteral, nasal and oral applications focuses on the development of innovative and affordable drugs with a special focus on poorly soluble small and large molcules.

Our purpose is with novel technologies and innovative services to drive the development of highly effective medicines for everyone to improve peoples lives.

Code of Business Conduct

The reputation of the HWI group, the trust in us as business partners and the sustainable success of our company are important to us. Values such as personal responsibility, integrity and transparency, as well as legally compliant and ethically correct behaviour at all times; they are firmly established in our daily actions and in our corporate culture.

Our Code of Conduct reflects the standards we set for ourselves, our owners, our directors, our managers and each of our employees. It serves as a guideline, provides orientation and defines our basic rules and principles.

History

1991

1991 - Foundation

Foundation of HWI ANALYTIK GmbH in Rheinzabern with analytical services for medicinal products and related products as well as isolation and purification of enzymes

» History HWI group

1995

1995 - Relocation

Business relocation within the Rheinzabern site: Relocation to new GMP laboratories and offices on the premises of Rats-Apotheke in Hauptstraße 28, New: Qualification of pharmaceutical reference standards, Establishment of a laboratory unit for isolation and purification of natural products from medicinal plants, 8 employees

» History HWI group

2003

2003 - Business expansion

Business expansion: Relocation of the Isolation of Natural Products Department to a second site in Römerbadstraße, Rheinzabern, 30 employees

» History HWI group

2006

2006 - Foundation

Foundation of i.DRAS GmbH in Planegg/Martinsried. Relocation of drug regulatory affairs services from HWI to i.DRAS.

» History HWI group

2008

2008 - Foundation

Foundation of Sercona GmbH (Appenweier) as a subsidiary of HWI ANALYTIK by takeover of the department for formulation development of medicinal products from a CMO with 25 employees. Purchase of the pharmaceutical laboratory LAZ from Prof. Dr. Hamacher in Tübingen. Capacity expansion of GMP laboratory in Rülzheim. Relocation of company headquarters of HWI ANALYTIK from
Rheinzabern to Rülzheim. 65 employees (HWI ANALYTIK).

» History HWI group

2015

2015 - Location and brand HWI

Purchase of previously rented premises of Rheinzaberner Straße 8 in Ruelzheim. Establishment of the brand HWI group.
130 employees in HWI group.

» History HWI group

2020

2020 - Frankfurt Site

HWI group takes over the Frankfurt development site of Losan Pharma GmbH. HWI is thus further developing its strategy towards high potent active ingredients and sterile dosage forms

HWI receives funding from the Innovation and Technology Support Programme (InnoTop) Rhineland-Palatinate for the project: Establishment of an innovative screening and technology platform for the fast, flexible and cost-efficient development and production of parenteral (sterile) drug formulations for poorly soluble chemical and biological agents through further development of nanotechnology.

» History HWI group

2019

2019 - Master plan for Rülzheim site

Master plan for the development of the HWI's own site in Rülzheim. Purchase of further 400 m² adjacent premises in Rülzheim.
160 employees in HWI group.
Change of corporate name of i.DRAS GmbH to HWI regulatory services GmbH.

HWI receives funding from the programme Artificial Intelligence as a Driver for Economically Relevant Ecosystems for the project: Digital Vigilance Services - software solutions (neural networks).

» History HWI group

From 1991 until today

HWI pharma services was founded in Rheinzabern in the Southern Palatinate in 1991 by Dr. Stefan Wissel and Professor Dr. Hanns Häberlein – at that time under the name HWI ANALYTIK. The first letters of the names Häberlein and Wissel gave rise to the name HWI. The addition “Analytik” describes the young entrepreneurs’ focus of activities at that time, which lay on the processing of analytical issues for medicinal products and related products.

Read for yourself how the success story has progressed!

» History HWI group